Daybu

trofinetide · Acadia Pharmaceuticals B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Daybu, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: EMA Opinion under re-examination: Daybu (trofinetide) — Acadia Pharmaceuticals B.V.